Sema BOZALİOĞLU, Nedret KILIÇ, Zuhal YILDIRIM, Bilkay BAŞTÜRK, Osman KURUKAHVECİOĞLU

The relationship between HLA-G levels and oxidative stress parameters in patients with breast cancer

To investigate serum HLA-G levels and its correlation with oxidative stress and antioxidant parameters in breast cancer patients. Materials and methods: The patient group consisted of 25 individuals with breast cancer who were operated on in the General Surgery Department of Gazi University’s Faculty of Medicine. Thirty-one individuals who had no history of any kind of cancer, allergic diseases, diabetes, or rheumatic and immunological disease constituted the control group. Results: Results showed that malondialdehyde (MDA), advanced oxidation protein products (AOPPs), and HLA-G levels in the patient group were statistically and significantly high compared to the control group (P < 0.001). While vitamin C levels were significantly lower in the patient group (P < 0.05), an insignificant difference in glutathione peroxidase (GPx) and total sulfhydryl group (R-SH) levels in both groups was observed (P > 0.05). Serum superoxide dismutase (SOD) levels in the patient group were significantly low compared to the control group (P < 0.001). In the control group, statistically significant positive correlations among HLA-G, MDA (r = 0.580, P = 0.001), and AOPP (r = 0.569, P = 0.01) were observed. In the control group, a significant positive correlation in MDA and AOPP levels (r = 0.482, P = 0.006) was observed. Conclusion: Results of the present study indicated that there was a relationship between the oxidative stress and the deficiency of antioxidant defenses as lipid peroxidation, protein oxidation, and HLA-G expression increased.

Anahtar Kelimeler:

Key words: Oxidative stress, antioxidants, breast cancer, HLA-G

The relationship between HLA-G levels and oxidative stress parameters in patients with breast cancer

Keywords:

Key words: Oxidative stress, antioxidants, breast cancer, HLA-G,

PDF

___

Ferlay P, Autier M, Boniol M, Heanue M, Colombet M, Bolye P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581–92.
Ahmedin J, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics. CA Cancer J Clin 2007; 57: 43–66. 3. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer Statistics. CA Cancer J Clin 2004; 54: 8–29.
Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003; 544: 9–41.
Cook JA. The genetics and management of inherited gynaecological cancer (including breast). Curr Opin Obstet Gynaecol 2000; 10: 133–8.
Thibodeau PA, Kachadourian R, Lemay R, Bisson M, Day BJ, Paquette B. In vitro pro-and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 2002; 81: 227–36.
Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer 2003; 39: 2632–42.
Moe GW, Marin-Garcia J, Konig A, Goldenthal M, Lu X, Feng Q. In vivo tumor necrosis factor-(alpha) inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H1813–20.
Bonnefont-Rousselot D, Beaudeux JL, Therond P, Peynet J, Legrand A, Delattre J. Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 2004; 62: 147– 57.
Fang YZ, Yang S, Wu G. Free radicals, antioxidants and nutrition. Nutrition 2002; 18: 872–9.
Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1999; 91: 31–8.
Shackelford RE, Kaufmann WK, Paules RS. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 2002; 28: 1387–404.
Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002; 265: 49–72.
Cung-Man Ho J, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001; 61: 8578–85.
Gromadzinska J, Wasowicz W, Rydzynski K, Szeszenia- Dabrowska N. Oxidative stress markers in blood of lung cancer patients occupationally exposed to carcinogens. Biol Trace Elem Res 2003; 91: 203–15.
Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003; 95: 1312–9.
Gackowski D, Speina E, Zielinska M, Kowalewski J, Rozalski R, Siomek A, Paciorek T, Tudek B, Olinski R. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 2003; 63: 4899–902.
Sarıoğlu S, Kırımca F, Çavdar C, Türkmen M. Glomerular HLA DR DP DQ expression in renal diseases. Turk J Med Sci 2001; 31: 243–7.
Balcı AE, Etem EÖ, Çakmak M, Elyas H, Özyurtkan MO. Investigation of the HLA class I antigens in patients with primary spontaneous pneumothorax. Turk J Med Sci 2010; 40: 865–9.
Fons P, Chabot S, Cartwright JE, Lenfant F, L’Faqihi F, Giustiniani J, Herault JP, Gueguen G, Bono F, Savi P et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006; 108: 2608–15.
Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37: 1924–37.
Morales PJ, Gardner L, Sharkey AM, Holmes N, Moffett A. Synthesis of β2-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007; 122: 179–88.
Palmisano GL, Pistillo MP, Fardin P, Capanni P, Nicolo G, Salvi S, Spina B, Pasciucco G, Ferrara GB. Analysis of HLA-G expression in breast cancer tissues. Hum Immunol 2002; 63: 969–76.
Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, Zhang X, Cao FL, Zhang JG, Yan WH. Upregulation of human leukocyte antigen–G expression and its clinical significance in ductal breast cancer. Hum Immunol 2010; 71, 892–8.
Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen- Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304–13.
Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372–6.
Kurtel H, Granger DN, Tso P, Grisham MB. Vulnerability of intestinal interstitial fluid to oxidant stress. Am J Physiol 1992; 263: G573–8.
Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497–500.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–69.
Mapson LW. The estimation of dehydro-L-ascorbic acid when present in low concentration in tissues, by the Roe and Kuether procedure. Ann N Y Acad Sci 1961; 92: 284–5.
Rajnees CP, Manimaran A, Sasikala KR, Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J 2008; 49: 640–3.
Portakal O, Ozkaya O, Erden Inal M, Bozan B, Koşan M, Sayek I. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 2000; 33: 279– 84.
Zeiba M, Nowak D, Suwalski M, Piasecka G, Grzelewska- Rzymowska I, Tymińska K, Kroczyńska-Bednarek J, Kwiatkowska S. Enhanced lipid peroxidation cancer tissue homogenates in non-small cell lung cancer. Monaldi Arch Chest Dis 2001; 56: 110–4.
Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health 2001; 64: 213–22.
Khanzode SS, Muddeshwar MG, Khanzode SD, Dakhale GN. Antioxidant enzymes and lipid peroxidation in different stage of breast cancer. Free Radic Res 2004; 38: 81–5.
Sharhar S, Norman H, Fatimah A, Fadilah RN, Rohi GA, Amin I, Cham BG, Rizal RM, Fairulnizal MN. Antioxidant intake and status, and oxidative stress in relation to breast cancer risk: a case-control study. Asian Pac J Cancer Prev 2008; 9: 343–9.
Gerber M, Richardson S, Crastes de Paulet P, Pujol H, Crastes de Paulet A. Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Cancer 1989; 64: 2347–53.
Seven A, Erbil Y, Seven R. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem Biophys 1998; 16: 333–45.
Kayalı R, Çakatay U. Basic mechanisms of protein oxidation. Cerrahpaşa J Med 2004; 35: 83–9.
Badid N, Ahmed FZB, Merzouk H, Belbraouet S, Mokhtari N, Merzouk SD, Benhabib R, Hamzaoui D, Narce M. Oxidant/ antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 2010; 16: 159–67.
Iscan M, Coban T, Cok I, Bulbul D, Eke BC, Burgaz S. The organochloride pesticide residues and antioxidant enzyme activities in human breast tumors: is there any association? Breast Cancer Res 2002; 72: 173.
Himmetoğlu S, Dinçer Y, Ersoy YE, Bayraktar B, Celik V, Akcay T. DNA oxidation and antioxidant status in breast cancer. J Investig Med 2009; 57: 720–3.
Gibanananda R, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SA. Lipid peroxidation, free radical and antioxidant status in breast cancer. Clin Pharm Ther 2000; 59: 163–70.
Sinha RJ, Singh R, Mehrotra S, Singh RK. Implication of free radicals and antioxidant levels in carcinoma of the breast: a never-ending battle for survival. Indian J Cancer 2009; 46: 146–50.
Kasapovic J, Pejic S, Todorovic A, Stojiljkovic V, Pajovic SB. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 2008; 26: 723–30.
Data K, Sinha S, Chattopadhyay P. Reactive oxygen species in health and disease. Natl Med J India 2000; 13: 304–310.
Yeh CC, Hou MF, Tsai SM, Lin SK, Hsiao JK, Huang JC, Wang LH, Wu SH, Has LA, Ma H et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta 2005; 361: 104–11.
Vandana S, Ram S, Ilavazhagan M, Kumar GD, Banerjee PK. Comparative cytoprotective activity of vitamin C, E and beta- carotene against chromium induced oxidative stress in murine macrophages. Biomed Pharmacoter 2006; 60: 71–6.
Cunningham ML, Lokesh BR. Superoxide anion generated by potassium superoxides cytotoxic and mutagenic to Chinese hamster ovary cells. Mutat Res 1983; 121: 299–304.
Torun M, Yardım S, Gönenç A, Sargın H, Menevşe A, Şimşek B. Serum beta-carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. J Clin Pharm Ther 1995; 20: 259–63.
Michels KB, Holmberg L, Bergkvist L, Ljung H, Bruce A, Wolk A. Dietary antioxidation vitamins, retinol and breast cancer incidence in cohort of Swedish women. Int J Cancer 2001; 91: 563–7.
Nissen SB, Tjonneland A, Stripp C, Olsen A, Christensen J, Overvad KO. Intake of vitamins A, C, and E from diet and supplements and breast cancer in postmenopausal women. Cancer Causes Control 2003; 14: 695–704.
Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P. Specific activation of the non-classical class 1 histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Am J Pathol 2002; 196: 266–74.
Tripathi P, Agrawal S. Non-classical HLA-G antigen and its role in the cancer progression. Cancer Invest 2006; 24: 178–186.
Maier S, Geraghty DE, Weiss EH. Expression and regulation of HLA-G in human glioma cell lines. Transplant Proc 1999; 31: 1849–53.
Carosella ED, Moreau P, LeMaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008; 29: 125–32.
Le Maoult, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A, Carosella ED. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007; 109: 2040–8.
Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, Le Maoult J. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007; 26: 1423–33.